Zobrazeno 1 - 10
of 362
pro vyhledávání: '"LaMarche MJ"'
Autor:
Kombo DC; Department of Medicinal Chemistry, Integrated Drug Discovery, Sanofi, Cambridge, Massachusetts, USA., LaMarche MJ; Department of Medicinal Chemistry, Integrated Drug Discovery, Sanofi, Cambridge, Massachusetts, USA., Konkankit CC; Department of Chemistry and Chemical Biology, Baker Laboratory, Cornell University, Ithaca, New York, USA., Rackovsky S; Department of Chemistry and Chemical Biology, Baker Laboratory, Cornell University, Ithaca, New York, USA.
Publikováno v:
Proteins [Proteins] 2024 Oct; Vol. 92 (10), pp. 1234-1241. Date of Electronic Publication: 2024 May 29.
Autor:
Kombo DC; Integrated Drug Discovery, Sanofi, 350 Water St., Cambridge, Massachusetts 02141, United States., Stepp JD; Integrated Drug Discovery, Sanofi, 350 Water St., Cambridge, Massachusetts 02141, United States., Lim S; Integrated Drug Discovery, Sanofi, 350 Water St., Cambridge, Massachusetts 02141, United States., Elshorst B; CMC Synthetics Early Development Analytics, Sanofi, Industriepark Hochst, Frankfurt 65926, Germany., Li Y; Integrated Drug Discovery, Sanofi, 350 Water St., Cambridge, Massachusetts 02141, United States., Cato L; Molecular Oncology, Sanofi, 350 Water St., Cambridge, Massachusetts 02141, United States., Shomali M; Molecular Oncology, Sanofi, 350 Water St., Cambridge, Massachusetts 02141, United States., Fink D; Integrated Drug Discovery, Sanofi, 350 Water St., Cambridge, Massachusetts 02141, United States., LaMarche MJ; Integrated Drug Discovery, Sanofi, 350 Water St., Cambridge, Massachusetts 02141, United States.
Publikováno v:
ACS omega [ACS Omega] 2024 Jun 18; Vol. 9 (26), pp. 28691-28706. Date of Electronic Publication: 2024 Jun 18 (Print Publication: 2024).
Autor:
Visser M; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Papillon JPN; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Luzzio M; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., LaMarche MJ; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Fan J; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Michael W; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Wang D; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Zhang A; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Straub C; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Mathieu S; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Kato M; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Palermo M; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Chen C; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Ramsey T; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Joud C; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Barrett R; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Vattay A; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Guo R; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Bric A; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Chung F; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Liang G; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Romanowski MJ; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Lam J; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Thohan S; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Atassi F; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Wylie A; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Cooke VG; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Jan 25; Vol. 67 (2), pp. 1447-1459. Date of Electronic Publication: 2024 Jan 10.
Autor:
Liu C; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Lu H; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Wang H; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Loo A; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Zhang X; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Yang G; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Kowal C; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Delach S; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Wang Y; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Goldoni S; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Hastings WD; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Wong K; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Gao H; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Meyer MJ; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Moody SE; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., LaMarche MJ; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Engelman JA; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Williams JA; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Hammerman PS; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Abrams TJ; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Mohseni M; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Caponigro G; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. hxhao81@gmail.com giordano.caponigro@novartis.com., Hao HX; Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. hxhao81@gmail.com giordano.caponigro@novartis.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jan 01; Vol. 27 (1), pp. 342-354. Date of Electronic Publication: 2020 Oct 12.
Autor:
LaMarche MJ; Integrated Drug Discovery, Sanofi, 350 Water St., Cambridge, Massachusetts 02141, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2022 Sep 08; Vol. 65 (17), pp. 11478-11484. Date of Electronic Publication: 2022 Aug 18.
Autor:
Yang, Xiaojuan1 (AUTHOR), Wu, Hong1,2 (AUTHOR) wuhong@scu.edu.cn
Publikováno v:
Journal of Hematology & Oncology. 11/9/2024, Vol. 17 Issue 1, p1-31. 31p.
Autor:
Vemulapalli V; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, United States.; Department of Biological Chemistry & Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, United States., Chylek LA; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States., Erickson A; Department of Cell Biology, Harvard Medical School, Boston, United States., Pfeiffer A; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark., Gabriel KH; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, United States.; Department of Biological Chemistry & Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, United States., LaRochelle J; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, United States.; Department of Biological Chemistry & Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, United States., Subramanian K; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States., Cao R; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, United States., Stegmaier K; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, United States., Mohseni M; Novartis Institutes for Biomedical Research, Cambridge, United States., LaMarche MJ; Novartis Institutes for Biomedical Research, Cambridge, United States., Acker MG; Novartis Institutes for Biomedical Research, Cambridge, United States., Sorger PK; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States., Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, United States., Blacklow SC; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, United States.; Department of Biological Chemistry & Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, United States.
Publikováno v:
ELife [Elife] 2021 Mar 23; Vol. 10. Date of Electronic Publication: 2021 Mar 23.
Autor:
Wang Y; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Mohseni M; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Grauel A; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Diez JE; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Guan W; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Liang S; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Choi JE; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Pu M; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Chen D; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Laszewski T; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Schwartz S; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Gu J; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Mansur L; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, USA., Burks T; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, USA., Brodeur L; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Velazquez R; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Kovats S; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Pant B; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Buruzula G; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Deng E; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Chen JT; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Sari-Sarraf F; Analytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Cambridge, USA., Dornelas C; Analytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Cambridge, USA., Varadarajan M; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Yu H; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Liu C; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Lim J; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Hao HX; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Jiang X; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Malamas A; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., LaMarche MJ; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, USA., Geyer FC; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., McLaughlin M; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Costa C; Oncology Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland., Wagner J; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Ruddy D; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Jayaraman P; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Kirkpatrick ND; Analytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Cambridge, USA., Zhang P; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Iartchouk O; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, USA., Aardalen K; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Cremasco V; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Dranoff G; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Engelman JA; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Silver S; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Wang H; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Hastings WD; Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA. bill.hastings@novartis.com., Goldoni S; Oncology Disease Area, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA. s.goldoni22@gmail.com.
Publikováno v:
Scientific reports [Sci Rep] 2021 Jan 14; Vol. 11 (1), pp. 1399. Date of Electronic Publication: 2021 Jan 14.
Autor:
LaMarche MJ, Acker M, Argintaru A, Bauer D, Boisclair J, Chan H, Chen CH, Chen YN, Chen Z, Deng Z, Dore M, Dunstan D, Fan J, Fekkes P, Firestone B, Fodor M, Garcia-Fortanet J, Fortin PD, Fridrich C, Giraldes J, Glick M, Grunenfelder D, Hao HX, Hentemann M, Ho S, Jouk A, Kang ZB, Karki R, Kato M, Keen N, Koenig R, LaBonte LR, Larrow J, Liu G, Liu S, Majumdar D, Mathieu S, Meyer MJ, Mohseni M, Ntaganda R, Palermo M, Perez L, Pu M, Ramsey T, Reilly J, Sarver P, Sellers WR, Sendzik M, Shultz MD, Slisz J, Slocum K, Smith T, Spence S, Stams T, Straub C, Tamez V Jr, Toure BB, Towler C, Wang P, Wang H, Williams SL, Yang F, Yu B, Zhang JH, Zhu S
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Nov 25; Vol. 63 (22), pp. 13578-13594. Date of Electronic Publication: 2020 Sep 24.
Autor:
Lu H; Novartis Institutes for Biomedical Research, Oncology Disease Area, Cambridge, Massachusetts, USA., Liu C; Novartis Institutes for Biomedical Research, Oncology Disease Area, Cambridge, Massachusetts, USA., Huynh H; Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, National Cancer Centre, Singapore., Le TBU; Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, National Cancer Centre, Singapore., LaMarche MJ; Novartis Institutes for Biomedical Research, Global Discovery Chemistry, Cambridge, Massachusetts, USA., Mohseni M; Novartis Institutes for Biomedical Research, Oncology Disease Area, Cambridge, Massachusetts, USA., Engelman JA; Novartis Institutes for Biomedical Research, Oncology Disease Area, Cambridge, Massachusetts, USA., Hammerman PS; Novartis Institutes for Biomedical Research, Oncology Disease Area, Cambridge, Massachusetts, USA., Caponigro G; Novartis Institutes for Biomedical Research, Oncology Disease Area, Cambridge, Massachusetts, USA., Hao HX; Novartis Institutes for Biomedical Research, Oncology Disease Area, Cambridge, Massachusetts, USA.
Publikováno v:
Oncotarget [Oncotarget] 2020 Jan 21; Vol. 11 (3), pp. 265-281. Date of Electronic Publication: 2020 Jan 21 (Print Publication: 2020).